secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2022-07-08T23:59:59+00:00
Accession:  0001193805-22-001069
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic appoints Maria Törnsén to Board of Directors; Jan Van den Bossche resigns
--------------------------------------------------------------------------------

- Appointed Maria Törnsén as Class III director, effective July 5, 2022, term until 2023 annual meeting.
- Granted option to purchase 30,000 shares: 10,000 vesting monthly over 1 year, 20,000 over 3 years.
- Jan Van den Bossche resigned from Board, effective July 5, 2022; no disagreement with company.
- Törnsén brings 20 years commercial experience; current CCO at Passage Bio, previous roles at Sarepta, Sanofi, Shire.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380522001069/0001193805-22-001069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380522001069/e621820_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-22-001069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer